Eli Lilly's (LLY) stock surges 14% as its diabetes drug orforglipron meets Phase 3 goals, cutting weight by 8%. Read more ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Dolo-650, a common name in nearly every Indian household, is now under scrutiny. Widely used to relieve fever, headaches, and ...

The CAC 40 (Cotation Assistée en Continu) is the leading index of the Paris stock exchange and is regarded as a market indicator for the general retail trends on the Euronext Paris stock exchange.

A new decade brings new skin concerns. “Aging seems to appear rather dramatically and suddenly in your 40s due to the onset of hormonal changes,” says Dr. Zenovia Gabriel, a Newport Beach ...

Magna International Inc. Announces Date for Q4 & Year End 2024 Results and 2025 Outlook Webcast ...